The problem with that scenario is the 525mg data s

The problem with that scenario is the 525mg data showed an almost exact efficacy as the 700mg and was more than enough for approval. Cytodyn wanted to go with the 525mg because all the data was ready to go. If the FDA went with the 525mg we could have had approval prior to when COVID-19 exploded in the U.S. and tens of thousands of lives could have been saved. Yet they still insist on delaying that approval based on the spurious need for data from an entirely different trial.